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ABSTRACT
Introduction: As a multifactorial disease, temporomandibular disorders (TMD) require 
a complex therapeutic approach, being noninvasive therapies the first option for most 
patients. The aim of this study was to perform a systematic review to analyze the most 
common non-invasive therapies used for TMD management.
Methods: The review was done by searching electronic databases to identify controlled 
clinical trials related to pharmacologic and non-invasive treatments. Of all potential 
articles found, 35 were included in this review.
Results: Low-level laser therapy (LLLT), occlusal splints (OS) and oral exercises/
behavior education (OE/BE) were the most common therapies used. LLLT showed 
significant results in pain and movement improvement in most studies. OS was usually 
combined to other therapies and resulted in improvement of pain. OE/BE showed 
significant results when combined with ultrasound, LLLT, and manual therapy.
Conclusions: Non-invasive treatments can provide pain relief and should be prescribed 
before surgical procedures. LLLT was the therapy with the higher number of studies showing 
positive results. Based in heterogeneity of treatment protocols, diagnostic and outcomes 
criteria used, new well-designed randomized controlled trials (RCT) are necessary.
Keywords: Temporomandibular disorder; temporomandibular joint; myofascial pain; 
treatment; temporomandibular dysfunction; pharmacologic
Temporomandibular disorders (TMD) are the most common chronic 
orofacial pain conditions. TMD include several clinical disabilities affecting the 
temporomandibular joint (TMJ) and masticatory muscles. Mainly characterized 
by pain, movement limitation, and TMJ sounds, TMD are usually associated 
with headache, cervical dysfunction, and other related signs and symptoms1-5. 
Pain is the most debilitating symptom, interfering with daily activities, quality 
of sleep, and psychological aspects as anxiety, stress, and depression6.
As multifactorial disorders, TMDs require a multidisciplinary approach. 
Usually, first treatment options are noninvasive treatments, including occlusal 
splint (OS), photobiomodulation (PBM), manual therapy (MT), electrotherapy, 
acupuncture, oral exercises and behavioral education therapies (OE/BE), as 
well as pharmacological therapy7-13. The primary goal of noninvasive therapies 
is pain relief, avoiding acute pain to become a chronic condition, which leads 
to changes of pain perception and delay of treatment responses4,6,10,14,15.
Occlusal splint (OS)
Among management possibilities, OS is the most frequently recommended. 
OS is a removable appliance that covers all the occlusal and incisal surfaces 
of teeth in the upper or lower jaw6,10,11. Although the mode of action of OS is not 
fully clear, studies show that it promotes bilateral balancing and protects teeth 
Management of temporomandibular disorders
Brochado
1 Departamento de Patologia Oral, 
Faculdade de Odontologia, Universidade 
Federal do Rio Grande do Sul (UFRGS). 
Porto Alegre, RS, Brasil.
2 Departamento de Medicina Oral, Hospital 
de Clínicas de Porto Alegre (HCPA). 
Porto Alegre, RS, Brasil.
3 Departamento de Odontologia 
Conservadora, Faculdade de 
Odontologia, Universidade Federal do 





Faculdade de Odontologia, Universidade 
Federal do Rio Grande do Sul (UFRGS)
Rua Ramiro Barcelos, 2492, sala 503.
90035-003, Porto Alegre, RS, Brasil.
Management of temporomandibular disorders
http://seer.ufrgs.br/hcpa Clin Biomed Res 2019;39(3) 231
NoN-iNvasive therapies for maNagemeNt of 
temporomaNdibular disorders:  
a systematic review
Fernanda Thomé Brochado1, Luciano Henrique de Jesus1,  
Manoela Domingues Martins1,2, Karen Dantur Chaves3, 
from wear caused by bruxism6,10,16. There are many 
types of OS with different indications and functions1,13,17. 
The most used are the stabilization splints, also known 
as Michigan splints. Usually made with hard acrylic, 
the splint is designed to provide a temporary and 
ideal occlusion leading to neuromuscular balance 
and decreasing muscle tension1,13,17,18.
Low-level laser therapy (LLLT) –  
Photobiomodulation Therapy
LLLT is the application of light within the red and 
near infra-red wavelength range of 600-1000 nm. It is 
a non-ablative and non-thermal light4,7,8,19, which has 
been widely used due its low cost, easy application, 
and short treatment time3. There is evidence that LLLT 
modulates the inflammatory process, reduces pain and 
edema, and increases blood circulation and extensibility 
of the nervous system4. In addition, no side effect is 
reported when correctly administered20. The clinical 
efficacy of TMD is controversial due to the difference in 
parameters, dosimetry, and assessment criteria used by 
studies, besides the clinical variability of TMD patients. 
For TMD symptoms, the commonly used wavelength 
is in the infrared spectrum from 780 nm to 904 nm3-7.
Therapeutic ultrasound (US) 
US is the application of mechanical vibrations, 
known as sound energy, at increasing frequencies 
above 16 Hz generated by a piezoelectric effect using 
a frequency between 1.0 and 3.0 MHz. It is useful in 
fresh injuries with acute inflammation21,22. The right 
dosimetry ensures an optimal outcome with minimum 
risk of adverse effects21. Another useful application of 
ultrasound is in the administration of anti-inflammatory 
ointments with a hand-held transducer. The energy 
forces the diffusion of medications through the skin 
to target underneath soft tissues. This method is 
called phonophoresis21.
Transcutaneous electrical nerve stimulation 
(TENS) 
Among therapies for TMD, TENS has been 
proposed as a safe and noninvasive therapy with 
low-voltage electrical pulses. Using electrodes on 
the skin over the painful area, TENS can modulate 
the control system of endogenous pain promoting 
pain relief and reduction of muscular activity6,22,23. 
There are two theories explaining its action on pain 
modulation. One theory suggests that the rhythmic 
contractions of muscles caused by TENS increase 
blood and lymph circulation, resulting in the decrease 
of interstitial swelling and improvement of the 
circulation of noxious tissue metabolites, leading 
to muscle relaxation22,24. The other theory is based 
on gate control, which preconizes that the electrical 
stimulus travels faster in afferent fibers of large 
diameters closing the pain gates of the spinal cord24.
Manual therapy (MT)
MT has been increasingly used due to the positive 
outcomes in some musculoskeletal and hypomobility 
conditions25,26. In masticatory muscles, MT promotes 
muscular relaxation, stimulates joint proprioception, 
relieves pain, and improves mandibular movements26. 
The literature reports that MT is an important method 
that promotes the release of opioid and non-opioid 
substances and inhibitory neurotransmitters that 
act in the central nervous system. Moreover, some 
studies suggest that MT can decrease the EMG 
activity in masticatory muscles26-28.
Oral exercises and behavioral education (OE/BE)
Self-management (SM) or self-care includes 
cognitive behavioral therapies as education about 
negative habits and counseling, relaxation techniques, 
and home exercises6. There is poor evidence of its 
effectiveness due to the differences on prescription12,29. 
Benefits of exercises include decrease in pain 
due to the release of endogenous non-opioid and 
opioid substances by stretching and strengthening 
masticatory muscles, increasing mobility, and tissue 
regeneration4-6,12,29. Stretching and relaxation exercises 
are first recommended when pain is present, helping 
patients to overcome the fear of moving the TMJ6,29. 
However, most studies compare these exercises with 
other therapies, which makes it difficult to evaluate the 
real effectiveness of this therapy alone25,29-31. While 
some studies indicate therapeutic exercises and BE 
as an essential part of treatment, others show the 
difficulties to define one program, since there is no 
established and tested gold standard for SM programs 
yet. In fact, previous studies present inconsistent 
results of therapeutic exercises and SM programs5,6,32.
Acupuncture
This millenary Chinese therapeutic method consists 
of placing needles into the skin for pain management. 
The technique uses specific acupoints and painful 
points. A variation of traditional acupuncture that 
has been widely used is dry needling, which applies 
needles with vigorous stimulation at trigger points33-35. 
Although several explanations are proposed, the mode 
of action is not fully clear. It is accepted that the needle 
penetration causes a micro-inflammation process 
improving blood circulation and neurotransmitters 
release, such as serotonin, encephalin, and endorphin, 
which prevent the propagation of painful stimuli36-38. 
In addition, acupuncture promotes muscle relaxation, 
reestablishing body and mind balance, with recent 
studies showing benefits in anxiety, depression, and 
insomnia6,36,37. For TMD patients, acupuncture is 
suggested as an adjunctive and important method 
with positive effects such as decreased muscle 
tension and pain35.
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Pharmacological treatments
Pharmacological treatment is a common approach 
for orofacial pain as a monotherapy or associated 
with other therapies and surgical interventions. Used 
alone, it is considered a palliative therapy39,40. The 
most commonly used drugs to decrease pain and 
inflammatory process in joints and/or muscles are 
myorelaxants, non-steroidal anti-inflammatory drugs 
(NSAIDs), analgesics, tricyclic antidepressants (TCAs), 
benzodiazepines, and corticosteroids9,39,41. A wide 
range of pharmacotherapeutic agents is available; 
however, there is a lack of scientific evidence and 
no conclusive result for any of these drugs for the 
TMD population6,10,39,42.
Many clinical trials were performed with controversial 
results. Therefore, the main question of our review 
was: “Are non-invasive therapies effective to decrease 
pain and improve movements in TMD patients?”.
METHODS
Search strategy and inclusion criteria
The bibliographical search was performed between 
January and August 2019. PubMed, Embase, and 
Scielo databases were used in two independent 
searches to identify relevant randomized clinical 
trials (RCTs) using non-invasive therapies in TMD 
patients, performed in the last 12 years. The first 
search used the keywords “temporomandibular 
disorder” OR “temporomandibular joint” AND 
“myofascial pain” AND “treatment”. The second used 
the search terms “temporomandibular dysfunction” 
AND “pharmacologic”. In addition, a hand search in 
the reference lists of included articles was done to 
identify other relevant studies and review articles.
Data collection and analysis
Two reviewers independently identified titles and 
abstracts resulting from the search strategy for potentially 
eligible studies. Duplicate items were removed as well 
as studies with surgical intervention, invasive therapies, 
and rheumatic and neurologic diseases. Afterwards, 
a full text reading was performed for final eligibility.
Data extraction
The data and results of each included study were 
extracted using a standard form. All data were cross-
checked by a second reviewer. Any lack of agreement 
was resolved by discussion. The data analysis was 
based on the type of intervention and outcomes. The 
primary outcome of interest for this review was pain and 
the secondary outcome was range of motion (ROM).
Methodological quality assessment
The Cochrane risk of bias tool43 was used to assess 
the methodological quality of the studies according to 
the following domains: random sequence generation, 
allocation concealment, blinding, incomplete data, 
selective reporting and other potential sources of bias.
RESULTS
Literature search
The initial search found 517 articles about therapies 
and 128 articles about pharmacological treatments, 
resulting in 645 articles. Of these, 557 were excluded 
due to duplications, invasive therapies or surgical 
procedures, reviews, and case reports. A total of 
82 articles were selected for full text reading (63 about 
therapies and 25 about pharmacological treatment) 
and finally 35 articles were included in this systematic 
review (Figure 1).
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Potencial relevant articles found by descriptors:
• Therapies (n = 517)
• Pharmacologic (n = 128)
Duplicated articles (excluded)
• Therapies (n = 52)
• Pharmacologic (n = 16)
Excluded articles 
(not meet inclusion criteria)
• Therapies (n = 402)





• Rheumatic and 
  neurologic disease
• Study in process
• Performed in the last 
  10 years
Excluded articles 
(not meet inclusion criteria)
• Therapies (n = 34)
• Pharmacologic (n = 19)
Screened by title/abstract
• Therapies (n = 465)
• Pharmacologic (n = 112)
Full text available
• Therapies (n = 63)
• Pharmacologic (n = 25)
Included articles
• Therapies (n = 29)
• Pharmacologic (n = 6)
Total included articles 
(n = 35)
Study characteristics and interventions
The main characteristics of the 35 included studies 
are described in Chart 1a and Chart 1b. The sample 
sizes ranged between 12 and 104 individuals with 
TMD symptoms, including men and women allocated 
in the same comparison group, except three studies 
that included only women4,44,45.
Of all the included studies, 13 (37%) used 
OS1,10,16,36,46-54, 12 (34%), OE/BE1,5,16,25,27,31,47,48,50-52,54, 12 
(34%), LLLT2,5,15,20,24,44,55,57-60, 7 (20%), MT5,25,27,47,52,54,61, 
4 (11%), acupuncture33,36,46,62, 3 (9%), NSAIDs10,44,53, 
3 (9%), TENS22,24,54, 2 (6%), US22,31, one (3%) 
benzodiazepine58, one (3%) TCAs and Gabapentin59, 
and one (3%), melatonin45.
Fourteen studies (40%) did not use control or 
placebo groups for comparison with the test therapy. 
The comparison of techniques using 2 or more groups 
was done in 30 (86%) studies2,5,10,24,33,44,45,54-59,61-63.
Risk of bias is shown in Chart 2. A total of 29 (82%) 
studies presented low risk1,2,5,10,15,16,20,24,25,27,31,33,36,45-
48,50,51,54-59,61-64 and three (9%) presented high risk44,49,61. 
Other three (9%) studies showed an unclear risk of 
bias due to insufficient information in at least one 
domain22,52,53.
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Chart 2: Risk of bias
Ismail et al., 2007
Mejersjo et al., 2008
Carrasco et al., 2008
Cuccia et al., 2009
Felicio et al., 2009
Fernández-Carnero et al., 2010
Mazzeto et al., 2010
Pramod et al., 2011
Kalamir et al., 2011
Itoh et al., 2012
Vicente-Barreto et al., 2012
Niemela et al., 2012
Michelotti et al., 2012
Vidor et al., 2013
Salmos-Brito et al., 2013
Tuncer et al., 2013
Ahari et al., 2014
Pereira et al., 2014
Katyayan et al., 2014
Ucar et al., 2014
Grillo et al., 2015
Sancakli et al., 2015
Varoli et al., 2015
Qvintus et al., 2015
Haviv et al., 2015
Machado et al., 2016
Ferreira et al., 2016
Cavalcanti et al., 2016
Rai et al., 2016
Grootel et al., 2017
Seifi et al., 2017
Huttuten et al., 2018
Brochado et al., 2018
Borges et al., 2018






















































































To assess the presence of TMD, as well as 
the type of disorder and diagnosis of myofascial 
pain, 24 (68%) studies applied the standardized 
evaluation protocol, the Research Diagnostic 
Criteria for Temporomandibular Disorders (RDC/
TMD)1,2,5,10,15,16,20,22,27,31,45-49,50,54,56,58,61,62,64, three (9%) 
used the Helkimo index49,53,54, and two (6%) applied 
the Fonseca questionnaire44,63. The remaining 8 (23%) 
studies adopted non-standard evaluation protocols, 
using clinical evaluation to include patients with signs 
and symptoms of TMD24,25,33,36,51,52,55,57.
All studies evaluated the outcomes at baseline 
and after the treatment protocol61, with number of 
sessions varying from 1 week to 1 year. Pain levels 
were assessed as the primary outcome in all studies 
using Visual Analogic Scale (VAS) in 29 (83%) 
studies1,2,10,15,16,22,24,25,31,33,36,45-59,61-64 or an algometer 
to evaluate the pressure pain threshold in 5 (14%) 
studies2,36,46,58,62; one study (3%) used the Verbal 
Pain Scale59. The results of an intragroup analysis 
demonstrated that 27 (77%)5,10,20,22,24,25,27,31,33,36,44,45,46,47,50,52-63 
of the studies presented reduction in pain and 22 
(62%)2,5,10,15,20,24,25,31,36,44-47,52-54,56,57,59,60,62,64, improvement 
in function. Among them, LLLT (34%)2,515,20,24,44,55-58,63,64, 
OE/BE (28%)5,16,21,25,27,47,48,50,51,54, and OS (31%)1,10,16,36,46-51,53,54 
were the most used. When analyzing the differences 
between treatments at the end of the protocols 
(intergroup analysis), 20 (57%) of the studies 
showed no significant difference in the levels of 
pain1,2,10,15,16,24,31,33,36,44,46-49,51-53,59,63,64.
In terms of secondary outcome measures, 
changes in mouth opening were evaluated in 29 
(82%) studies. A millimeter ruler was used in 10 
(29%) studies15,24,25,31,33,36,46,56,57,63 and a caliper in 4 
(11%)1,27,52,58. The remaining 6 (17%) studies did not 
describe the secondary outcome10,44,45,49,53,60. Significant 
improvement in mouth opening was described only 
in 13 (37%) studies using LLLT (17%)15,20,24,56,57,64, 
acupuncture (6%)36,62, MT (6%)25,52, TENS (3%)24, OMT 
(3%)54, and benzodiazepine (3%)59. The combination 
of MT and OE/BE (9%)5,25,54 or LLLT and OE (3%)5 
had significantly better results than the therapies 
alone or placebo.
DISCUSSION
Non-invasive therapies have been recommended 
as first choice treatment for TMD arousing the interest 
of many authors who attempted to find a gold standard 
treatment protocol6,7. Despite the wide use of these 
therapies in clinical practice, the efficacy of most of 
them in TMD is still controversial, probably due to 
the variety of parameters and protocols7,60,65. Our 
results demonstrated that non-invasive therapies 
presented a low positive response, found in only 
43% of the studies. Among them, OS, OE/BE and 
LLLT were the most commonly used. LLLT was the 
treatment with the highest rate of improved TMD 
symptoms. The absence of a placebo or a control 
group was noteworthy. The included RCTs had good 
methodological quality with low risk of bias.
The correct diagnostic of TMD is complex but 
essential to decide treatment strategies and follow 
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the patients. The diagnosis is usually based on 
validated questionnaires and clinical tests4,7. The 
RDC/TMD is one of the most used instruments which 
classified the types and subtypes of TMD (axis I) 
and information related to psychosocial aspects 
(axis II) of patients6,8. Our review showed that 24 
(68%)1,2,5,10,15,16,20,22,27,31,45-49,50,54,56,58,61,62,64 studies used a 
gold standard method (RDC/TMD-axis I) to diagnose 
TMD, which ensures a good analysis of the effects of 
therapies. Only few studies applied other validated 
index, such as Helkimo’s49,53,54 and Fonseca44,64, to 
assess the severity of TMD symptoms, but these 
questionnaires present some limitations and are not 
able to provide sufficient information to classify TMD 
dysfunction44,53,54. Besides that, our results showed 
only one study63 that considered the psychosocial 
aspects and their influence on primary and secondary 
outcomes. TMD treatment has been considered a 
challenge because of its multifactorial origin, including 
a complex interaction among physical, behavioral, 
social, and psychological factors49,52,60. Based on 
these aspects, the analysis of the impact of treatment 
strategies based on the perspective of quality of life 
has been currently suggested. Therefore, new clinical 
trials involving TDM treatment should include Axis II 
of RDC and other questionnaires of anxiety and/or 
quality of life.
Pain is well known as the main symptom of 
TMD leading the patients to incapacity and a poor 
quality of life.7 Corroborating with these, our review 
showed that all analyzed studies evaluated pain as 
the primary outcome. VAS was the most common 
strategy to evaluate the levels of pain in 29 (83%) 
studies1,2,10,15,16,22,24,25,31,33,36,45-53,55-59,61-64. Another 
important outcome observed in the studies analyzed 
was mouth opening2,5,10,15,20,24,25,31,36,44-47,52-54,56,57,59,60,62,64. 
This is an important aspect to be addressed because 
it can interfere with patient’s daily activities such as 
chewing, oral hygiene, smiling and others.
Interestingly, results were observed regarding the 
effect of different non-invasive therapies especially 
evaluating pain (main outcome). Analyzing intragroup 
data, all therapies demonstrated positive effect to 
relieve pain comparing the baseline with the end 
of the treatment. However, the intergroup analysis 
(comparison among groups) does not demonstrate 
the same positive results. Only 15 (43%) of the 
35 studies presented significant difference between 
groups. The LLLT presented better results in most of 
the studies evaluating pain (17%)5,20,55-58 and range 
of movement (17%)2,15,20,56,57,59.
The interest on LLLT is increasing, since its 
application is easy with no reported side effects4. 
Different parameters, such as number of sessions, sites 
of application, and dosimetry have been described, 
which indicate that this is a controversial therapy3. Some 
authors believe that 8 sessions with applications twice 
a week promote positive effects52,57. However, other 
authors2,5,15,56 propose 12 sessions. In addition, two 
authors applied the therapy using 320 or 4 sessions24 
during only one week, although they found inconsistent 
results. LLLT application points also varied among 
studies, being the most common the jaw, masseter, 
temporalis, and pterygoid muscles (intraorally)2,56. 
Better results in pain and mobility were described 
using pre-established muscular points (masseter, 
temporalis, and pterygoid) or trigger points2 rather 
than the joint points. In addition, the infrared laser 
provides better results in the long term (180 days) 
compared with red laser. However, short-term effects 
did not show statistical difference between red and 
infrared wavelengths20. One recent study64, compared 
different protocols of LLLT (830 nm) showing that 
8J/cm2 is more effective to improve mouth opening 
than 60 J/cm2 or 105 J/cm2. However, all protocols 
of LLLT promoted pain relief.
The OS is widely recommended49 and is one of 
the most used treatments in the RCTs included in the 
present review. However, the analysis of our results 
showed that its benefits in improving TMD symptoms 
are controversial6,49 especially because OS had been 
used in combination with other therapies. Among the 
12 studies that used OS1,10,16,36,46-51,53,54, only 4 (33%) 
used as an individual treatment option and showed 
reduction in pain36,46,49,54. The other studies compared 
the effects of OS with acupuncture36,46, Manual 
therapy55 and/or NSAIDs10,53 and showed improvement 
in pain in all different treatment groups. These results 
indicated that all of these treatments reduced pain 
and can be applied alone or in combination as good 
choice for TMD patients.
Another non-invasive therapy commonly used in 
our review was OE/BE. Like OS, OE/BE had been 
used in clinical trials mostly in combination with 
other therapies. In general, among the 10 studies 
included, 6 (60%) showed positive results with 
decrease of TMD symptoms5,25,27,50,52,54. It is difficult 
to compare the results among studies due to the 
differences in exercise protocols, time of duration 
of the treatment that varied from 101,48,51 to 45 min47 
and from 2 to 3 times/day1,31,48,51 to 2 times/week25,47. 
Two studies used a very well-designed protocol 
called oral myofunctional therapy which combined 
BE instruction, oral, respiratory and cervical exercises 
with thermotherapy and self-massage. Both evidenced 
positive results in improvement of pain and masticatory 
function in OE/BE group5,54.
Pharmacological treatment is frequently 
recommended for orofacial pain42; however, we found 
only 6 (18%) RTCs using pharmacological treatments 
for TMD. Most of the existing literature evaluating 
pharmacologic treatments are observational clinical 
studies instead of RCTs40,59. The selected studies 
evaluated the effects of benzodiazepine (16%)59, 
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anti-inflammatory (33%)10,53, myorelaxant drugs 
(16%)44, melatonin (16%)45, and TCA and gabapentin 
(16%)60. Positive improvements were found only 
with melatonin45. Besides that, significant results for 
pain spread were found using gabapentin60. These 
results indicated that more clinical trials studies are 
necessary to evaluate the impact of pharmacological 
treatment in TMD patients.
CONCLUSION
TMD is a complex musculoskeletal disorder 
with several clinical, psychological, and behavioral 
components, leading to a difficult standardization of 
protocols and treatment evaluation. In this review, 
non-invasive therapies were the first choice for TMD 
patients and all of them improve, at least partially, 
TMD signs and symptoms. Therefore, noninvasive 
treatments can provide pain relief and should be 
prescribed before surgical procedures. LLLT, OS, 
OE/BE were the most commonly used therapies. 
LLLT was the therapy with the higher number 
of studies showing positive results compared to 
placebo, control, or other therapies. In general, 
important heterogeneity in treatment protocols, 
diagnostic and outcomes criteria was observed 
indicating the necessity of new well-designed 
randomized controlled trials.
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